Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,898 | 56,566 | 15,047 | 39,545 | 12,610 |
| Marketable Securities | 11,863 | N/A | N/A | N/A | N/A |
| Receivables | 55 | N/A | 5,557 | 8,011 | 20,570 |
| TOTAL | $23,792 | $58,907 | $22,098 | $50,192 | $34,455 |
| Non-Current Assets | |||||
| PPE Net | 15,368 | 19,737 | 23,251 | 24,315 | 14,846 |
| Other Non-Current Assets | 5,035 | 5,298 | 5,557 | 6,635 | 7,237 |
| TOTAL | $20,403 | $25,034 | $28,808 | $30,949 | $22,083 |
| Total Assets | $44,196 | $83,941 | $50,905 | $81,141 | $56,538 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,695 | 946 | 3,679 | 4,459 | 7,382 |
| Accrued Expenses | 5,473 | 6,692 | 9,918 | 12,456 | 1,905 |
| Other current liabilities | N/A | N/A | N/A | 6,341 | 17 |
| TOTAL | $7,980 | $10,813 | $14,993 | $26,455 | $11,062 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 542 | N/A | 172 |
| Deferred Revenues | N/A | 1,322 | N/A | 100 | 100 |
| Other Non-Current Liabilities | 6,970 | 12,410 | 682 | 12,373 | 2,373 |
| TOTAL | $10,246 | $15,829 | $4,853 | $16,136 | $6,468 |
| Total Liabilities | $18,226 | $26,642 | $19,847 | $42,591 | $17,530 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,289 | 9,225 | 5,040 | 4,296 | N/A |
| Common Shares | 1 | 1 | 1 | 4 | 3 |
| Retained earnings | -124,169 | -90,064 | -47,870 | -29,129 | -11,984 |
| Other shareholders' equity | 344 | 505 | 479 | 0 | 0 |
| TOTAL | $25,970 | $57,299 | $31,058 | $38,550 | $39,008 |
| Total Liabilities And Equity | $44,196 | $83,941 | $50,905 | $81,141 | $56,538 |